These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22116990)

  • 21. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphodiesterase type 5 inhibitors in the management of non-neurogenic male lower urinary tract symptoms: critical analysis of current evidence.
    Martínez-Salamanca JI; Carballido J; Eardley I; Giuliano F; Gratzke C; Rosen R; Salonia A; Stief C
    Eur Urol; 2011 Sep; 60(3):527-35. PubMed ID: 21684677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
    Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
    JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Update of PDE5 inhibitors as treatment of ED].
    Lu YN; Chen B
    Zhonghua Nan Ke Xue; 2005 Jul; 11(7):552-5. PubMed ID: 16078679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension].
    Sakuma M; Shirato K
    Nihon Rinsho; 2008 Nov; 66(11):2157-61. PubMed ID: 19051736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Phosphodiesterase type 5 inhibitors in the treatment of pulmonary arterial hypertension].
    Kiliçkesmez K; Küçükoğlu MS
    Anadolu Kardiyol Derg; 2010 Sep; 10 Suppl 2():16-8. PubMed ID: 20819751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of heart failure management in the elderly population.
    Cheng JW; Nayar M
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):233-49. PubMed ID: 19948300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is there a place for treatment with type 5 phosphodiesterase inhibitors in heart failure patients?].
    Josiak K; Inorowicz E; Kremis E; Jankowska EA; Banasiak W; Ponikowski P
    Kardiol Pol; 2011; 69(9):952-7. PubMed ID: 21928210
    [No Abstract]   [Full Text] [Related]  

  • 29. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
    Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
    J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and safety of phosphodiesterase 5 inhibitors in the treatment of erectile dysfunction].
    Shen ZJ; Yu YL
    Zhonghua Nan Ke Xue; 2005 Aug; 11(8):631-4. PubMed ID: 16138588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicenter, double-blind, placebo-controlled study of sildenafil citrate in Canadian men with erectile dysfunction and untreated symptoms of depression, in the absence of major depressive disorder.
    Kennedy SH; Dugré H; Defoy I
    Int Clin Psychopharmacol; 2011 May; 26(3):151-8. PubMed ID: 21471773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy and safety of sildenafil therapy in pulmonary artery hypertension: a meta-analysis].
    Kuang TG; Wang J; Zhai ZG; Guo XH; Wang C
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1021-4. PubMed ID: 17672963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sildenafil for pulmonary hypertension complicating bronchopulmonary dysplasia.
    Bhatt-Mehta V; Donn SM
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):393-5. PubMed ID: 24866752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six months of Sildenafil therapy improves heart rate recovery in patients with heart failure.
    Guazzi M; Arena R; Pinkstaff S; Guazzi MD
    Int J Cardiol; 2009 Aug; 136(3):341-3. PubMed ID: 18667251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac uses of phosphodiesterase-5 inhibitors.
    Schwartz BG; Levine LA; Comstock G; Stecher VJ; Kloner RA
    J Am Coll Cardiol; 2012 Jan; 59(1):9-15. PubMed ID: 22192662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
    Doggrell S
    Int J Impot Res; 2007; 19(3):281-95. PubMed ID: 17183346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of oral sildenafil in severe pulmonary arterial hypertension: clinical efficacy and dose response relationship.
    Garg N; Sharma MK; Sinha N
    Int J Cardiol; 2007 Sep; 120(3):306-13. PubMed ID: 17174417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphodiesterase type 5 inhibitors: the day after.
    Hatzimouratidis K; Hatzichristou D
    Eur Urol; 2007 Jan; 51(1):75-88; discussion 89. PubMed ID: 16949200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of sildenafil citrate in treating erectile dysfunction in patients with combat-related post-traumatic stress disorder: a double-blind, randomized and placebo-controlled study.
    Safarinejad MR; Kolahi AA; Ghaedi G
    BJU Int; 2009 Aug; 104(3):376-83. PubMed ID: 19389004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.